相关实验视频

Updated: May 23, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

在固体瘤中利用HER2向的双类抗体

Xinlin Liu¹, Xinyi Fan², Xiang Gao²

¹The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266071, China; Qingdao Cancer Institute, Qingdao 266071, China.

Pharmacological research

|March 7, 2025

概括

针对HER2的双形抗体 (bpAbs) 在固体瘤中表现有前途. 本综述对比了当前针对HER2的bpAbs,它们的机制,局限性以及癌症治疗中的未来潜力.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

双类型抗体 (bpAbs) 通过向单个抗原上的多个表位体,比单类型抗体具有优势.
它们已成为癌症和传染病的强效治疗剂,特别是在传统治疗不足的情况下.

研究的目的:

审查和比较已确定的HER2向bpAbs.的临床性能.
阐明它们的作用机制,局限性和潜在的组合疗法.
为突出 HER2 阳性固体癌症的有前途的研究bpAbs.

主要方法:

文献综述和对HER2向bpAbs. 的临床数据的比较分析.
检查作用机制和治疗限制.
识别和讨论新兴的基于bpAbs的代理商.

主要成果:

针对HER2的bpAbs已经证明,在患有依赖HER2的固体瘤的患者中,生存率有所改善.
已建立的bpAbs显示了不同的临床性能配置文件,机制和局限性.
新兴的基于bpAbs的药物显示出治疗HER2阳性固体癌症的前景.

结论:

针对HER2的bpAbs代表了癌症治疗的重大进步,提供了更高的疗效和更好的患者结果.
对它们的机制,局限性和组合策略的进一步研究对于优化它们的治疗应用至关重要.
研究中的bpAbs有可能扩大对HER2阳性固体瘤的治疗选择.

关键词:

这是一种双方形抗体.临床疗效临床疗效在HER2中,HER2是HER2.作用机制作用机制固体瘤是一个固体瘤.

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...